Preclinical Development and Emerging Strategies for Design of Selective Kinase Inhibitors Targeting Brain Metastasis of Resistant HER2+ Breast Cancer. Grant uri icon

abstract

  • Title: Preclinical Development and Emerging Strategies for Design of Selective Kinase Inhibitors Targeting Brain Metastasis of Resistant HER2+ Breast Cancer.
    Total award: $30,000, funded by PVAMU and Texas A&M partner for research and scholarly collaboration (Panther-RISE Grant Awards)
    Role: PI (Texas A&M University, with Collaboration with Victoria Mgbemena (PI: PVAMU College of Arts & Sciences)

date/time interval

  • 2021 - 2022